DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ftvmlh/global) has announced the addition of the "Global Gastroesophageal Reflux Disease Pipeline Highlights - 2014" report to their offering.
The latest report Gastroesophageal Reflux Disease Pipeline Highlights - 2014, provides most up-to-date information on key pipeline molecules in the global gastroesophageal reflux disease market. It covers emerging therapies for gastroesophageal reflux disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides gastroesophageal reflux disease pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides gastroesophageal reflux disease pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides gastroesophageal reflux disease pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which gastroesophageal reflux disease pipeline products will be launched in the US and Ex-US till 2017.
Key Topics Covered:
1. Gastroesophageal Reflux Disease Pipeline by Stages
2. Gastroesophageal Reflux Disease Pipeline by Drug Class
3. Gastroesophageal Reflux Disease Pipeline by Company
4. Gastroesophageal Reflux Disease Phase 3 Clinical Trial Insights
5. Gastroesophageal Reflux Disease Phase 2 Clinical Trial Insights
6. Gastroesophageal Reflux Disease Phase 1 Clinical Trial Insights
7. Gastroesophageal Reflux Disease Preclinical Research Insights
8. Gastroesophageal Reflux Disease Discovery Stage Insights
9. Appendix
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/ftvmlh/global
